Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Gowling WLG

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
CPHI Shenzhen
Not Confirmed

Gowling WLG

Canada
arrow
CPHI Shenzhen
Not Confirmed

Trastuzumab Emtansine

Brand Name : KADCYLA

Patent Number : 2370466

Filing Date : 2000-06-23

Strength per Unit : 20 mg / mL

Dosage Form : Powder for Solution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2020-06-23

Date Granted : 2011-02-08

blank

02

Gowling WLG

arrow
CPHI Shenzhen
Not Confirmed

Gowling WLG

Country
arrow
CPHI Shenzhen
Not Confirmed

Trastuzumab Emtansine

Brand Name : KADCYLA

Patent Number : 2370466

Filing Date : 2000-06-23

Strength per Unit : 20 mg / mL

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2020-06-23

Date Granted : 2011-02-08

blank